Skip to content

A randomised trial of transvaginal tape (TVT) versus transvaginal obturator tape (TVTO): a pilot study

A randomised controlled pilot study comparing transvaginal obturator tape (TVTO) to transvaginal tape (TVT) for the treatment of genuine stress incontinence in women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86612493
Enrollment
40
Registered
2010-10-21
Start date
2004-08-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress urinary incontinence Urological and Genital Diseases Urinary incontinence

Interventions

This is a pilot single centre un-blinded randomised controlled trial with a 12 month follow-up. Randomisation is independently prepared numbered opaque sealed envelopes stored independently from the t

Sponsors

University of Aberdeen
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged over 18 years 2. Urodynamic stress incontinence 3. Failed conservative treatment 4. Being offered surgery

Exclusion criteria

Exclusion criteria: 1. Not prepared to accept surgery 2. Requiring additional prolapse surgery 3. Undergone previous surgery for stress urinary incontinence 4. Not completed their families, i.e., will still want children 5. Unable or unwilling to give informed consent 6. Unwilling to participate in follow-up

Design outcomes

Primary

MeasureTime frame
1. Changes in International Consultation on Incontinence Questionnaire (ICIQ), assessed at baseline 2. Differences in quality adjusted life years (QALYs) estimated from responses to the EQ-5D, measured at baseline and 12 months

Secondary

MeasureTime frame
1. Subjective cure rate 2. Changes in the King's Health questionnaire (KHQ) scores 3. Difference in EQ-5D scores at three and twelve months follow-up 4. Operative data 5. Self-reported acceptability 6. Usage recommendation to a friend All measured at baseline, two weeks (except for the EQ-5D), three months and twelve months.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026